# Sex-specific association between triglyceride-glucose index and all-cause mortality in patients with osteoporotic fractures: a retrospective cohort study

**Authors:** Shao-han Guo, Jian Xu, Ya-qin Gong, Wen-bin Hu, Chong Li, Ke Lu

PMC · DOI: 10.3389/fendo.2025.1574238 · Frontiers in Endocrinology · 2025-04-30

## TL;DR

This study finds that the triglyceride-glucose index is linked to mortality risk in patients with osteoporotic fractures, but the relationship differs between men and women.

## Contribution

The study reveals sex-specific differences in how the triglyceride-glucose index relates to mortality in osteoporotic fracture patients.

## Key findings

- In female patients, higher triglyceride-glucose index values correlated with increased mortality risk.
- Male patients with the highest triglyceride-glucose index tertile had lower mortality risk than those with the lowest tertile.
- The association between triglyceride-glucose index and mortality varied significantly by sex.

## Abstract

Osteoporotic fractures (OPFs) pose a considerable global health burden and are linked with an elevated mortality risk. The triglyceride-glucose index (TyG-I) is a recognized marker of insulin resistance across various populations. The association between all-cause mortality (ACM) and the TyG-I has been widely investigated in a variety of clinical settings. The potential sex-specific differences in this association among OPF patients remain uncertain.

In this retrospective cohort study, 2,307 patients ≥ 50 years old admitted to the hospital between January 2018 and August 2023 for surgical treatment of OPFs were included. The TyG-I was determined using fasting triglyceride and glucose levels measured at admission. The association between ACM and the TyG-I was evaluated by Cox proportional hazards regression, adjusting for possible confounding variables. Analyses were categorized by sex, and subgroup analyses evaluated possible interaction effects. The ACM rates among TyG-I tertiles were compared via Kaplan–Meier curves.

This research study analyzed 2,307 patients, of whom 247 (10.71%) died from any cause during the follow-up period. In females, a linear association of the TyG-I with ACM was observed even after adjusting for confounders, with each unit increase in the TyG-I correlating with a 37% increased risk of death (HR: 1.37, 95% CI: 1.06-1.77, p = 0.02). However, in males, there was a non-linear correlation, where patients in the uppermost TyG-I tertile showed a substantially decreased mortality risk relative to those in the lowest tertile (HR: 0.53, 95% CI: 0.30–0.92, p = 0.02). TyG-I indicated a statistically significant relation with sex (P for interaction = 0.01).

In patients diagnosed with OPFs, distinct sex-specific variations were observed in the relationship between ACM and the TyG-I. Among female patients, each unit increase in the TyG-I was linked to a 37% greater risk of mortality. Conversely, male patients within the highest TyG-I tertile indicated a lower mortality risk than those in the lowest tertile. Further research is required to confirm these sex-specific associations.

## Full-text entities

- **Genes:** UOX (urate oxidase (pseudogene)) [NCBI Gene 391051] {aka UOXP, URICASE}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** CVD (MESH:D002318), overweight (MESH:D050177), Fragility Fracture (MESH:D005600), impaired glucose metabolism (MESH:D044882), OPFs (MESH:D058866), IR (MESH:D007333), humerus fractures (MESH:D006810), Obesity (MESH:D009765), ischemic stroke (MESH:D002544), metabolic disruptions in bone metabolism (MESH:D001851), osteoporosis (MESH:D010024), hip (MESH:D025981), hyperinsulinemia (MESH:D006946), bone fragility (MESH:C536063), ACM (MESH:D003643), inflammation (MESH:D007249), elevated blood pressure (MESH:D006973), metabolic abnormalities (MESH:D008659), TyG-I (MESH:C566031), Health Problems (MESH:D000076082), atherosclerosis (MESH:D050197), trauma (MESH:D014947), hip fracture (MESH:D006620), diabetes (MESH:D003920), fracture (MESH:D050723), chronic coronary syndrome (MESH:D054058)
- **Chemicals:** Calcium (MESH:D002118), TG (MESH:D014280), UA (MESH:D014527), lipid (MESH:D008055), glycerophospholipids (MESH:D020404), FBG (-), Arsenazo III (MESH:D001150), Cr (MESH:D003404), acylcarnitines (MESH:C116917), nitric oxide (MESH:D009569), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12074978/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12074978/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12074978/full.md

---
Source: https://tomesphere.com/paper/PMC12074978